Table 2 Prevalence of MTX-related symptoms in MTX-tolerant and MTX-intolerant patients
Symptoms | MTX-intolerant N = 26 (%) | MTX-tolerant N = 94 (%) |
|---|---|---|
Abdominal pain | ||
After taking MTX | 12 (46.15) | 3 (3.19) |
Anticipatory | 2 (7.69) | 2 (2.12) |
Associative | 3 (11.53) | 1 (1.06) |
Nausea | ||
After taking MTX | 24 (92.30) | 44 (46.80) |
Anticipatory | 18 (69.23) | 7 (7.44) |
Associative | 22 (84.61) | 13 (13.82) |
Vomiting | ||
After taking MTX | 8 (30.76) | 9 (9.57) |
Anticipatory | 2 (7.69) | 1 (1.06) |
Behavioral complaints | ||
Restlessness | 20 (76.92) | 10 (10.63) |
Crying | 11 (42.30) | 1 (1.06) |
Irritability | 20 (76.92) | 7 (7.44) |
Refusal of MTX | 16 (61.53) | 4 (4.25) |